
-
Wimbledon defends electronic line-calling after Raducanu criticism
-
Farrell says Lions will learn from stuttering Waratahs win
-
Fernando's 4-35 restricts Bangladesh to 248 in 2nd Sri Lanka ODI
-
Prolific Jordan closes on All Blacks try record in nervy France win
-
Rahul and Pant extend India's lead over England in second Test
-
FIA urges neutrality after Mayer launches presidency bid
-
Leclerc tops final red-flagged practice at Silverstone
-
Scrappy Lions put through paces by under-strength NSW Waratahs
-
Djokovic eyes Wimbledon century, Swiatek steps up challenge
-
French doctor handed 10-year jail term for abusing patients
-
Hat sales spike at sunny Wimbledon
-
New Zealand survive 'hell of a Test' against inexperienced France
-
Man City defender Walker joins Burnley
-
China's first Legoland opens to tourists in Shanghai
-
'Childhood dream': Seine reopens to Paris swimmers after century-long ban
-
Welsh 'scars' deepen after Japan loss extends losing streak to 18
-
Search continues after Pakistan building collapse kills 16
-
New Zealand struggle past under-strength France 31-27
-
Wallabies plan to throw everything at Fiji, says skipper Wilson
-
Dalai Lama, on eve of 90th, aims to live for decades more
-
Seine reopens to Paris swimmers after century-long ban
-
Trump evokes Russia sanctions after largest assault on Ukraine
-
Afghans both hopeful, disappointed after Russia's Taliban recognition
-
Scotland survive stirring Maori All Blacks comeback for 29-26 win
-
Search continues after Pakistan building collapse kills 14
-
Texas flood toll rises to 24 as rescuers search for missing children
-
Brazil starlet Estevao 'ready' for Chelsea move: Palmeiras coach
-
Texas flash flood death toll rises to 24
-
Chelsea edge Palmeiras to reach Club World Cup semis
-
Eight OPEC+ alliance members move toward output hike at meeting
-
Prayers for the Dalai Lama in the heart of Mongolian Buddhism
-
Rivals ready to rock as fans flood in for Tour de France opener
-
Djokovic banks on 'home' advantage against Davis Cup teammate at Wimbledon
-
Ozzy Osbourne set for swansong at Black Sabbath hometown gig
-
Family and football unite to bid Diogo Jota farewell
-
Bombers and a 'beautiful bill' -- Trump celebrates US Independence Day
-
Mbappe 'better' and ready for Real Madrid against Dortmund at Club World Cup
-
BRICS nations to denounce Trump tariffs
-
Ghim maintains one-shot lead at PGA's John Deere Classic
-
Bayern Club World Cup clash with PSG a 'perfect storm': Kompany
-
Al Hilal showed Saudi league not just about money, says Koulibaly
-
PSG 'dead' unless they keep improving: Luis Enrique
-
MLB Cubs smash team-record eight homers to crush Cardinals
-
Mark Snow, composer of 'X Files' theme, dead at 78
-
Trump signs 'big, beautiful' bill on US Independence Day
-
US sprinter Richardson seeks to kickstart season after February injury
-
West Indies and Australia 2nd Test finely poised
-
Bosnia ends warrant for Bosnian Serb leader after questioning
-
Germany see off Poland in Women's Euro 2025 opener
-
Alcaraz into Wimbledon last 16 as Sabalenka outlasts Raducanu

Japan drugmaker reports two more deaths in supplement scare
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.
The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.
Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.
"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.
It added it had been told separately that another person who had used Choleste Help in recent years had died.
"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.
"However, we decided to make this report public from the viewpoint of prompt disclosure."
Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.
Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.
The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.
Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".
The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.
Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.
The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.
Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".
But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.
C.Garcia--AMWN